Found: 11
Select item for more details and to access through your institution.
Base Editing and Prime Editing: Potential Therapeutic Options for Rare and Common Diseases.
- Published in:
- BioDrugs, 2023, v. 37, n. 4, p. 453, doi. 10.1007/s40259-023-00610-9
- By:
- Publication type:
- Article
Antibody–Drug Conjugates in the Treatment of Urothelial Cancer.
- Published in:
- BioDrugs, 2023, v. 37, n. 4, p. 505, doi. 10.1007/s40259-023-00606-5
- By:
- Publication type:
- Article
Historical Overview of Regulatory Approvals and PMDA Assessments for Biosimilar Products in Japan During 2009–2022.
- Published in:
- BioDrugs, 2023, v. 37, n. 4, p. 443, doi. 10.1007/s40259-023-00605-6
- By:
- Publication type:
- Article
The Role of Biologics in the Treatment of Chronic Rhinosinusitis.
- Published in:
- BioDrugs, 2023, v. 37, n. 4, p. 477, doi. 10.1007/s40259-023-00602-9
- By:
- Publication type:
- Article
Assessing the Interchangeability of AVT02 and Humira<sup>®</sup> in Participants with Moderate‑to‑Severe Chronic Plaque Psoriasis: Pharmacokinetics, Efficacy, Safety, and Immunogenicity Results from a Multicenter, Double-Blind, Randomized, Parallel-Group Study
- Published in:
- BioDrugs, 2023, v. 37, n. 4, p. 551, doi. 10.1007/s40259-023-00600-x
- By:
- Publication type:
- Article
CAR-T Cells and the Kidney: Insights from the WHO Safety Database.
- Published in:
- BioDrugs, 2023, v. 37, n. 4, p. 521, doi. 10.1007/s40259-023-00599-1
- By:
- Publication type:
- Article
Novel Immunotherapeutic Approaches for the Treatment of Glioblastoma.
- Published in:
- BioDrugs, 2023, v. 37, n. 4, p. 489, doi. 10.1007/s40259-023-00598-2
- By:
- Publication type:
- Article
Lupus Nephritis: New and Emerging Biologic and Targeted Therapies.
- Published in:
- BioDrugs, 2023, v. 37, n. 4, p. 463, doi. 10.1007/s40259-023-00597-3
- By:
- Publication type:
- Article
Factors Associated with Biosimilar Exclusions and Step Therapy Restrictions Among US Commercial Health Plans.
- Published in:
- BioDrugs, 2023, v. 37, n. 4, p. 531, doi. 10.1007/s40259-023-00593-7
- By:
- Publication type:
- Article
Recurring Fatigue After Biologic Administration: Patient-Reported Data from the Dutch Biologic Monitor.
- Published in:
- BioDrugs, 2023, v. 37, n. 4, p. 541, doi. 10.1007/s40259-023-00592-8
- By:
- Publication type:
- Article
Characterization for the Similarity Assessment between Proposed Biosimilar SB12 and Eculizumab Reference Product Using a State-of-the-Art Analytical Method.
- Published in:
- BioDrugs, 2023, v. 37, n. 4, p. 569, doi. 10.1007/s40259-023-00591-9
- By:
- Publication type:
- Article